- •Hematuria II: causes and investigation
- •Hematospermia
- •Lower urinary tract symptoms (LUTS)
- •Nocturia and nocturnal polyuria
- •Flank pain
- •Urinary incontinence in adults
- •Genital symptoms
- •Abdominal examination in urological disease
- •Digital rectal examination (DRE)
- •Lumps in the groin
- •Lumps in the scrotum
- •2 Urological investigations
- •Urine examination
- •Urine cytology
- •Radiological imaging of the urinary tract
- •Uses of plain abdominal radiography (KUB X-ray—kidneys, ureters, bladder)
- •Intravenous pyelography (IVP)
- •Other urological contrast studies
- •Computed tomography (CT) and magnetic resonance imaging (MRI)
- •Radioisotope imaging
- •Post-void residual urine volume measurement
- •3 Bladder outlet obstruction
- •Regulation of prostate growth and development of benign prostatic hyperplasia (BPH)
- •Pathophysiology and causes of bladder outlet obstruction (BOO) and BPH
- •Benign prostatic obstruction (BPO): symptoms and signs
- •Diagnostic tests in men with LUTS thought to be due to BPH
- •Why do men seek treatment for their symptoms?
- •Watchful waiting for uncomplicated BPH
- •Medical management of BPH: combination therapy
- •Medical management of BPH: alternative drug therapy
- •Minimally invasive management of BPH: surgical alternatives to TURP
- •Invasive surgical alternatives to TURP
- •TURP and open prostatectomy
- •Indications for and technique of urethral catheterization
- •Indications for and technique of suprapubic catheterization
- •Management of nocturia and nocturnal polyuria
- •High-pressure chronic retention (HPCR)
- •Bladder outlet obstruction and retention in women
- •Urethral stricture disease
- •4 Incontinence
- •Causes and pathophysiology
- •Evaluation
- •Treatment of sphincter weakness incontinence: injection therapy
- •Treatment of sphincter weakness incontinence: retropubic suspension
- •Treatment of sphincter weakness incontinence: pubovaginal slings
- •Overactive bladder: conventional treatment
- •Overactive bladder: options for failed conventional therapy
- •“Mixed” incontinence
- •Post-prostatectomy incontinence
- •Incontinence in the elderly patient
- •Urinary tract infection: microbiology
- •Lower urinary tract infection
- •Recurrent urinary tract infection
- •Urinary tract infection: treatment
- •Acute pyelonephritis
- •Pyonephrosis and perinephric abscess
- •Other forms of pyelonephritis
- •Chronic pyelonephritis
- •Septicemia and urosepsis
- •Fournier gangrene
- •Epididymitis and orchitis
- •Periurethral abscess
- •Prostatitis: presentation, evaluation, and treatment
- •Other prostate infections
- •Interstitial cystitis
- •Tuberculosis
- •Parasitic infections
- •HIV in urological surgery
- •6 Urological neoplasia
- •Pathology and molecular biology
- •Prostate cancer: epidemiology and etiology
- •Prostate cancer: incidence, prevalence, and mortality
- •Prostate cancer pathology: premalignant lesions
- •Counseling before prostate cancer screening
- •Prostate cancer: clinical presentation
- •PSA and prostate cancer
- •PSA derivatives: free-to-total ratio, density, and velocity
- •Prostate cancer: transrectal ultrasonography and biopsies
- •Prostate cancer staging
- •Prostate cancer grading
- •General principles of management of localized prostate cancer
- •Management of localized prostate cancer: watchful waiting and active surveillance
- •Management of localized prostate cancer: radical prostatectomy
- •Postoperative course after radical prostatectomy
- •Prostate cancer control with radical prostatectomy
- •Management of localized prostate cancer: radical external beam radiotherapy (EBRT)
- •Management of localized prostate cancer: brachytherapy (BT)
- •Management of localized and radiorecurrent prostate cancer: cryotherapy and HIFU
- •Management of locally advanced nonmetastatic prostate cancer (T3–4 N0M0)
- •Management of advanced prostate cancer: hormone therapy I
- •Management of advanced prostate cancer: hormone therapy II
- •Management of advanced prostate cancer: hormone therapy III
- •Management of advanced prostate cancer: androgen-independent/ castration-resistant disease
- •Palliative management of prostate cancer
- •Prostate cancer: prevention; complementary and alternative therapies
- •Bladder cancer: epidemiology and etiology
- •Bladder cancer: pathology and staging
- •Bladder cancer: presentation
- •Bladder cancer: diagnosis and staging
- •Muscle-invasive bladder cancer: surgical management of localized (pT2/3a) disease
- •Muscle-invasive bladder cancer: radical and palliative radiotherapy
- •Muscle-invasive bladder cancer: management of locally advanced and metastatic disease
- •Bladder cancer: urinary diversion after cystectomy
- •Transitional cell carcinoma (UC) of the renal pelvis and ureter
- •Radiological assessment of renal masses
- •Benign renal masses
- •Renal cell carcinoma: epidemiology and etiology
- •Renal cell carcinoma: pathology, staging, and prognosis
- •Renal cell carcinoma: presentation and investigations
- •Renal cell carcinoma: active surveillance
- •Renal cell carcinoma: surgical treatment I
- •Renal cell carcinoma: surgical treatment II
- •Renal cell carcinoma: management of metastatic disease
- •Testicular cancer: epidemiology and etiology
- •Testicular cancer: clinical presentation
- •Testicular cancer: serum markers
- •Testicular cancer: pathology and staging
- •Testicular cancer: prognostic staging system for metastatic germ cell cancer
- •Testicular cancer: management of non-seminomatous germ cell tumors (NSGCT)
- •Testicular cancer: management of seminoma, IGCN, and lymphoma
- •Penile neoplasia: benign, viral-related, and premalignant lesions
- •Penile cancer: epidemiology, risk factors, and pathology
- •Squamous cell carcinoma of the penis: clinical management
- •Carcinoma of the scrotum
- •Tumors of the testicular adnexa
- •Urethral cancer
- •Wilms tumor and neuroblastoma
- •7 Miscellaneous urological diseases of the kidney
- •Cystic renal disease: simple cysts
- •Cystic renal disease: calyceal diverticulum
- •Cystic renal disease: medullary sponge kidney (MSK)
- •Acquired renal cystic disease (ARCD)
- •Autosomal dominant (adult) polycystic kidney disease (ADPKD)
- •Ureteropelvic junction (UPJ) obstruction in adults
- •Anomalies of renal ascent and fusion: horseshoe kidney, pelvic kidney, malrotation
- •Renal duplications
- •8 Stone disease
- •Kidney stones: epidemiology
- •Kidney stones: types and predisposing factors
- •Kidney stones: mechanisms of formation
- •Evaluation of the stone former
- •Kidney stones: presentation and diagnosis
- •Kidney stone treatment options: watchful waiting
- •Stone fragmentation techniques: extracorporeal lithotripsy (ESWL)
- •Intracorporeal techniques of stone fragmentation (fragmentation within the body)
- •Kidney stone treatment: percutaneous nephrolithotomy (PCNL)
- •Kidney stones: open stone surgery
- •Kidney stones: medical therapy (dissolution therapy)
- •Ureteric stones: presentation
- •Ureteric stones: diagnostic radiological imaging
- •Ureteric stones: acute management
- •Ureteric stones: indications for intervention to relieve obstruction and/or remove the stone
- •Ureteric stone treatment
- •Treatment options for ureteric stones
- •Prevention of calcium oxalate stone formation
- •Bladder stones
- •Management of ureteric stones in pregnancy
- •Hydronephrosis
- •Management of ureteric strictures (other than UPJ obstruction)
- •Pathophysiology of urinary tract obstruction
- •Ureter innervation
- •10 Trauma to the urinary tract and other urological emergencies
- •Renal trauma: clinical and radiological assessment
- •Renal trauma: treatment
- •Ureteral injuries: mechanisms and diagnosis
- •Ureteral injuries: management
- •Bladder and urethral injuries associated with pelvic fractures
- •Bladder injuries
- •Posterior urethral injuries in males and urethral injuries in females
- •Anterior urethral injuries
- •Testicular injuries
- •Penile injuries
- •Torsion of the testis and testicular appendages
- •Paraphimosis
- •Malignant ureteral obstruction
- •Spinal cord and cauda equina compression
- •11 Infertility
- •Male reproductive physiology
- •Etiology and evaluation of male infertility
- •Lab investigation of male infertility
- •Oligospermia and azoospermia
- •Varicocele
- •Treatment options for male factor infertility
- •12 Disorders of erectile function, ejaculation, and seminal vesicles
- •Physiology of erection and ejaculation
- •Impotence: evaluation
- •Impotence: treatment
- •Retrograde ejaculation
- •Peyronie’s disease
- •Priapism
- •13 Neuropathic bladder
- •Innervation of the lower urinary tract (LUT)
- •Physiology of urine storage and micturition
- •Bladder and sphincter behavior in the patient with neurological disease
- •The neuropathic lower urinary tract: clinical consequences of storage and emptying problems
- •Bladder management techniques for the neuropathic patient
- •Catheters and sheaths and the neuropathic patient
- •Management of incontinence in the neuropathic patient
- •Management of recurrent urinary tract infections (UTIs) in the neuropathic patient
- •Management of hydronephrosis in the neuropathic patient
- •Bladder dysfunction in multiple sclerosis, in Parkinson disease, after stroke, and in other neurological disease
- •Neuromodulation in lower urinary tract dysfunction
- •14 Urological problems in pregnancy
- •Physiological and anatomical changes in the urinary tract
- •Urinary tract infection (UTI)
- •Hydronephrosis
- •15 Pediatric urology
- •Embryology: urinary tract
- •Undescended testes
- •Urinary tract infection (UTI)
- •Ectopic ureter
- •Ureterocele
- •Ureteropelvic junction (UPJ) obstruction
- •Hypospadias
- •Normal sexual differentiation
- •Abnormal sexual differentiation
- •Cystic kidney disease
- •Exstrophy
- •Epispadias
- •Posterior urethral valves
- •Non-neurogenic voiding dysfunction
- •Nocturnal enuresis
- •16 Urological surgery and equipment
- •Preparation of the patient for urological surgery
- •Antibiotic prophylaxis in urological surgery
- •Complications of surgery in general: DVT and PE
- •Fluid balance and management of shock in the surgical patient
- •Patient safety in the operating room
- •Transurethral resection (TUR) syndrome
- •Catheters and drains in urological surgery
- •Guide wires
- •JJ stents
- •Lasers in urological surgery
- •Diathermy
- •Sterilization of urological equipment
- •Telescopes and light sources in urological endoscopy
- •Consent: general principles
- •Cystoscopy
- •Transurethral resection of the prostate (TURP)
- •Transurethral resection of bladder tumor (TURBT)
- •Optical urethrotomy
- •Circumcision
- •Hydrocele and epididymal cyst removal
- •Nesbit procedure
- •Vasectomy and vasovasostomy
- •Orchiectomy
- •Urological incisions
- •JJ stent insertion
- •Nephrectomy and nephroureterectomy
- •Radical prostatectomy
- •Radical cystectomy
- •Ileal conduit
- •Percutaneous nephrolithotomy (PCNL)
- •Ureteroscopes and ureteroscopy
- •Pyeloplasty
- •Laparoscopic surgery
- •Endoscopic cystolitholapaxy and (open) cystolithotomy
- •Scrotal exploration for torsion and orchiopexy
- •17 Basic science of relevance to urological practice
- •Physiology of bladder and urethra
- •Renal anatomy: renal blood flow and renal function
- •Renal physiology: regulation of water balance
- •Renal physiology: regulation of sodium and potassium excretion
- •Renal physiology: acid–base balance
- •18 Urological eponyms
- •Index
176 CHAPTER 5 Infections and inflammatory conditions
Tuberculosis
Tuberculosis (TB) of the genitourinary (GU) tract is caused by Mycobacterium tuberculosis. TB predominantly affects Asian populations, with a higher incidence in males than females.
Pathogenesis
Primary TB
The primary granulomatous lesion forms in the mid to upper zone of the lung. It consists of a central area of caseation surrounded by epithelioid and Langhans giant cells, accompanied by caseous lesions in the regional lymph nodes.
There is early spread of bacilli via the bloodstream to the GU tract; however, immunity rapidly develops, and the infection remains quiescent. Acute diffuse systemic dissemination of tubercle bacilli can result in symptomatic military TB.
Post-primary TB
Reactivation of infection is triggered by immune compromise (including HIV). It is at this point that patients develop clinical manifestations.
Kidney
Hematogenous spread causes granuloma formation in the renal cortex, associated with caseous necrosis of the renal papillae and deformity of the calyces, leading to release of bacilli into the urine. This is followed by healing fibrosis and calcification, which causes destruction of renal architecture and autonephrectomy.
Ureters
Spread is directly from the kidney and can result in stricture formation (vesicoureteric junction, pelviureteric junction, and mid-ureteric) and ureteritis cystica.
Bladder
Infection is usually secondary to renal infection, although iatrogenic TB can be caused by intravesical BCG treatment for carcinoma in situ. The bladder wall becomes edematous, red, and inflamed, with ulceration and tubercles (yellow lesions with a red halo).
Disease progression causes fibrosis and contraction (resulting in a small capacity ‘thimble’ bladder), obstruction, and calcification.
Prostate and seminal vesicles
Hematogenous spread causes cavitation and calcification, with palpable, hard-feeling structures. Fistulae may form to the rectum or perineum.
Epididymis
Hematogenous spread results in a “beaded” cord. Infection may spread to the testis.
Presentation
Early symptoms include fever, lethargy, weight loss, night sweats, and UTI not responding to treatment. Later manifestations include LUTS, hematuria, and flank pain.
TUBERCULOSIS 177
Investigations
•Urine: At least 3 early morning urines (EMUs) are required, but often many more EMU specimens will be needed before a positive culture for TB is obtained. A typical finding is sterile pyuria (leukocytes, but no growth). Ziehl–Neelsen staining will identify these acidand alcoholfast bacilli (cultured on Lowenstein–Jensen medium).
•CXR and sputum
•Tuberculin skin test
•IVP or CT urogram: Findings include renal calcification (nephrocalcinosis), irregular calyces (“moth-eaten kidney”), infundibular stenosis, cavitation, pelviureteric and vesicoureteric obstruction, and a contracted, calcified bladder.
•Cystoscopy and biopsy
Treatment
Treatment is with 6 months of isoniazid, rifampicin, and pyrazinamide. Regular follow-up imaging with IVP is recommended to monitor for ureteric strictures, which may need stenting, nephrostomies, or ureteric reimplantation.
Severe bladder disease may require surgical augmentation, reconstruction, or urinary diversion.
178 CHAPTER 5 Infections and inflammatory conditions
Parasitic infections
Schistosomiasis (bilharziasis)
Urinary schistosomiasis is caused by the trematode (or fluke) Schistoma haematobium. It is endemic in Africa, Egypt, and the Middle East. Fresh water snails release the infective form of the parasite (cercariae), which can penetrate skin, and migrate to the liver (as schistosomules), where they mature. Adult flukes couple, migrate to vesical veins, and lay eggs (containing miracidia larvae), which leave the body by penetrating the bladder and entering the urine.
The disease has two stages: active (when adult worms are actively laying eggs) and inactive (when the adult has died, and there is a reaction to the remaining eggs). The development of squamous cell carcinoma of the bladder is result of the chronic inflammation.
Presentation
The first clinical sign is “swimmer’s itch”—a local inflammatory response. Other early manifestations include Katayama fever, a generalized allergic reaction, which includes fever, urticaria, lymphadenopathy, hepatosplenomegaly, and eosinophilia. Active inflammation results in hematuria, frequency, and terminal dysuria.
Investigation
•Midday urine specimen; bladder and rectal biopsies may contain eggs (distinguished by having a terminal spine).
•Serology tests (ELISA).
•Cystoscopy identifies eggs in the trigone (“sandy patches”).
•IVP or CT urogram may show a calcified, contracted bladder, and obstructive uropathy.
Treatment
Give praziquantel 40 mg/kg in 2 divided doses 4–6 hours apart. Alternative medications include metrifonate or niridazole.
Complications
Chronic infection can lead to obstructive uropathy, ureteric stenosis, renal failure, and bladder contraction, or ulceration. The most significant and concerning complication is the development of squamous cell carcinoma of the bladder that often presents at an advanced stage.
Hydatid disease
Infection occurs after ingestion of the dog parasite Echinococcus granulosus (tapeworm). Sheep are the intermediate hosts. Cases occur in the Middle East, Australia, and Argentina, with 3% affecting the kidneys. Large cysts form, which can be asymptomatic or present with flank pain. A peripheral eosinophilia is seen with a positive hydatid complement-fixation test. X-rays and CT scans show a thick-walled, fluid-filled spherical cyst with a calcified wall.
Medical treatment is with albendazole. Where surgical excision is indicated, cysts can be first sterilized with formalin or alcohol. Praziquantel is also recommended preoperatively or if cyst contents are spilt (which can provoke systemic anaphylaxis).
PARASITIC INFECTIONS 179
Genital filariasis
Lymphatic filariasis is caused by Wuchereria bancrofti nematode infection and is common in the tropics. Manifestations include funiculoepididymitis, orchitis, hydrocele, scrotal and penile elephantiasis, and lymph scrotum (edema).
Diagnosis is made on capillary finger-prick, or venous blood is used for thick blood microscopic thick film and serology.
Medical treatments include diethylcarbamazine, ivermectin, and albendazole.